ENST00000310373.7:c.1816T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000310373.7(GP6):​c.1816T>C​(p.Phe606Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.797 in 690,984 control chromosomes in the GnomAD database, including 221,911 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 44359 hom., cov: 31)
Exomes 𝑓: 0.81 ( 177552 hom. )

Consequence

GP6
ENST00000310373.7 missense

Scores

2
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.84

Publications

22 publications found
Variant links:
Genes affected
GP6 (HGNC:14388): (glycoprotein VI platelet) This gene encodes a platelet membrane glycoprotein of the immunoglobulin superfamily. The encoded protein is a receptor for collagen and plays a critical role in collagen-induced platelet aggregation and thrombus formation. The encoded protein forms a complex with the Fc receptor gamma-chain that initiates the platelet activation signaling cascade upon collagen binding. Mutations in this gene are a cause of platelet-type bleeding disorder-11 (BDPLT11). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
GP6-AS1 (HGNC:55305): (GP6 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0786426E-6).
BP6
Variant 19-55014129-A-G is Benign according to our data. Variant chr19-55014129-A-G is described in ClinVar as Benign. ClinVar VariationId is 257416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.826 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000310373.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GP6
NM_016363.5
MANE Select
c.*792T>C
3_prime_UTR
Exon 8 of 8NP_057447.5
GP6
NM_001083899.2
c.1816T>Cp.Phe606Leu
missense
Exon 8 of 8NP_001077368.2
GP6
NM_001256017.2
c.*792T>C
3_prime_UTR
Exon 7 of 7NP_001242946.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GP6
ENST00000310373.7
TSL:1
c.1816T>Cp.Phe606Leu
missense
Exon 8 of 8ENSP00000308782.3
GP6
ENST00000417454.5
TSL:1 MANE Select
c.*792T>C
3_prime_UTR
Exon 8 of 8ENSP00000394922.1
GP6
ENST00000333884.2
TSL:1
c.*792T>C
3_prime_UTR
Exon 7 of 7ENSP00000334552.2

Frequencies

GnomAD3 genomes
AF:
0.755
AC:
114725
AN:
151914
Hom.:
44351
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.570
Gnomad AMI
AF:
0.770
Gnomad AMR
AF:
0.802
Gnomad ASJ
AF:
0.792
Gnomad EAS
AF:
0.825
Gnomad SAS
AF:
0.722
Gnomad FIN
AF:
0.876
Gnomad MID
AF:
0.842
Gnomad NFE
AF:
0.832
Gnomad OTH
AF:
0.789
GnomAD2 exomes
AF:
0.798
AC:
103813
AN:
130156
AF XY:
0.795
show subpopulations
Gnomad AFR exome
AF:
0.563
Gnomad AMR exome
AF:
0.830
Gnomad ASJ exome
AF:
0.794
Gnomad EAS exome
AF:
0.837
Gnomad FIN exome
AF:
0.870
Gnomad NFE exome
AF:
0.825
Gnomad OTH exome
AF:
0.808
GnomAD4 exome
AF:
0.809
AC:
435962
AN:
538952
Hom.:
177552
Cov.:
3
AF XY:
0.807
AC XY:
235572
AN XY:
292034
show subpopulations
African (AFR)
AF:
0.564
AC:
8807
AN:
15618
American (AMR)
AF:
0.825
AC:
28347
AN:
34356
Ashkenazi Jewish (ASJ)
AF:
0.797
AC:
15735
AN:
19754
East Asian (EAS)
AF:
0.805
AC:
25160
AN:
31264
South Asian (SAS)
AF:
0.733
AC:
45371
AN:
61874
European-Finnish (FIN)
AF:
0.872
AC:
27972
AN:
32086
Middle Eastern (MID)
AF:
0.787
AC:
3149
AN:
4002
European-Non Finnish (NFE)
AF:
0.830
AC:
257494
AN:
310048
Other (OTH)
AF:
0.799
AC:
23927
AN:
29950
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
4766
9532
14299
19065
23831
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
986
1972
2958
3944
4930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.755
AC:
114778
AN:
152032
Hom.:
44359
Cov.:
31
AF XY:
0.758
AC XY:
56358
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.570
AC:
23620
AN:
41432
American (AMR)
AF:
0.802
AC:
12242
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.792
AC:
2747
AN:
3468
East Asian (EAS)
AF:
0.824
AC:
4263
AN:
5174
South Asian (SAS)
AF:
0.722
AC:
3481
AN:
4822
European-Finnish (FIN)
AF:
0.876
AC:
9251
AN:
10560
Middle Eastern (MID)
AF:
0.840
AC:
247
AN:
294
European-Non Finnish (NFE)
AF:
0.832
AC:
56564
AN:
67992
Other (OTH)
AF:
0.786
AC:
1661
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1343
2686
4029
5372
6715
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.797
Hom.:
120660
Bravo
AF:
0.742
TwinsUK
AF:
0.821
AC:
3045
ALSPAC
AF:
0.817
AC:
3149
ESP6500AA
AF:
0.677
AC:
2061
ESP6500EA
AF:
0.870
AC:
5295
ExAC
AF:
0.699
AC:
35526
Asia WGS
AF:
0.751
AC:
2612
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Platelet-type bleeding disorder 11 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.95
DANN
Benign
0.087
Eigen
Benign
-1.9
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.00094
N
MetaRNN
Benign
0.0000011
T
MetaSVM
Benign
-0.91
T
PhyloP100
-1.8
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
0.050
N
REVEL
Benign
0.028
Sift
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.013
MutPred
0.18
Gain of disorder (P = 0.1036)
MPC
0.19
ClinPred
0.00014
T
GERP RS
-0.47
gMVP
0.013
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1671150; hg19: chr19-55525497; COSMIC: COSV107378251; COSMIC: COSV107378251; API